Regenerative medicine bioprocessing: building a conceptual framework based on early studies

Area of Science:

• Biotechnology
• Regenerative Medicine
• Tissue Engineering

Background:

• Early regenerative medicine relied on manual, lab-based procedures for human cell and tissue production.
• Scaling up production presents significant challenges in bioprocessing and manufacturing.

Purpose of the Study:

• To review the evolution of regenerative medicine bioprocessing from manual to automated methods.
• To examine bioprocesses for autologous and allogeneic cell sources.
• To identify factors enabling economical, large-scale production of regenerative therapies.

Main Methods:

• Review of early studies in regenerative medicine.
• Analysis of bioprocessing requirements for autologous and allogeneic cell types.
• Examination of manufacturing challenges and potential solutions.

Main Results:

• Regenerative medicine is transitioning towards automated manufacturing.
• Distinct bioprocesses are required for autologous and allogeneic materials.
• Simplification is possible using allogeneic cell lines and derived tissues.

Conclusions:

• Automated bioprocessing is key for scaling regenerative medicine.
• Efficient production requires addressing challenges with both autologous and allogeneic cell sources.
• Economic viability depends on optimizing bioprocessing for mass production.